BETA

Activities of Miroslav POCHE related to 2018/2215(DEC)

Shadow reports (1)

REPORT on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking for the financial year 2017 PDF (179 KB) DOC (58 KB)
2016/11/22
Committee: CONT
Dossiers: 2018/2215(DEC)
Documents: PDF(179 KB) DOC(58 KB)

Amendments (6)

Amendment 3 #
Motion for a resolution
Paragraph 4
4. Regrets to note that payment appropriations were for the fourth consecutive year below 75 %: in 2017 they were at 71,96 %; notes, however, that the number of payments increased by 9,33 % (from 75 to 82) but the paid amount, however, was reduced by 19,87 % (from EUR 175 182 730 to EUR 140 381 318) compared to 2016; takes note that this low implementation was mainly due to a reduction or postponement of clinical trials within some large and complex projects of the anti-microbial resistance and eEbola programmes and to delays in concluding grant agreements for calls under Horizon 2020; invites the IMI 2 Joint Undertaking to present updated information to the discharge authority and to improve the payment appropriations for the procedure next year;
2019/01/30
Committee: CONT
Amendment 4 #
Motion for a resolution
Paragraph 4 a (new)
4 a. Welcomes that the number of payments increased by 9,33 % (from 75 to 82); points out that the paid amount decreased due to the higher amount of the costs recognised against pre-financing already paid to IMI 1 Joint Undertaking and IMI 2 Joint Undertaking projects (clearings increased by 189%, from EUR 20 347 000 to EUR 58 846 383);
2019/01/30
Committee: CONT
Amendment 5 #
Motion for a resolution
Paragraph 5
5. Notes with regret theAcknowledges the inherent limitations in the forecasting of payment appropriation process; notes with regret that these limitations result in weaknesses shown iwhen planning and monitoring payment appropriations, reflected in EUR 78 700 000 near the end of 2017 of unused payment appropriations from previous years; welcomes the corrective measures put in place by the IMI 2 Joint Undertaking to break the cycle of over budgeting; notes that the IMI 2 Joint Undertaking governing board decided to reduce the operational payment appropriations of the given year by EUR 56 000 000 and the accumulated unused from previous years by EUR 25 800 000;
2019/01/30
Committee: CONT
Amendment 6 #
Motion for a resolution
Paragraph 8
8. Notes with concern that out of the EUR 1 680 000 000 of Horizon 2020 funds allocated to the IMI Joint Undertaking, by the end of 2017 the IMI 2 Joint Undertaking had made commitments of EUR 819 010 000 (50 %) and payments of EUR 179 650 000 (10,97 % of the allocated funds and 21,93% of the committed funds) for the implementation of its first wave of project13 calls for proposals; acknowledges the fact that the low level of payments is mainly due to the time required by project consortia to conclude Horizon 2020 grant agreements with the industry partners, which delays IMI Joint Undertaking planned pre-financing for the given year, and due to the duration of the projects, often spanning over 5 years, bringing a large share of the payments beyond 2020;
2019/01/30
Committee: CONT
Amendment 8 #
Motion for a resolution
Paragraph 11
11. Welcomes that the absence of established key performance indicators (KPIs) is no longer an issue under Horizon 2020; regrets that less than 60 % of the third set of 2017 target KPIs were reachede slow progression in fulfilling some of the KPIs specific to IMI Joint Undertaking that were set for the duration of the whole programme (less than 60 % of the third set of 2017 target KPIs were reached); welcomes the IMI 2 Joint Undertaking governing board decision to approve a new set of IMI Joint Undertaking specific KPIs better aligned with the programme objectives;
2019/01/30
Committee: CONT
Amendment 11 #
Motion for a resolution
Paragraph 20
20. Welcomes the fact that the IMI 2 Joint Undertaking could reduce the delays in payments to beneficiarieadministrative payments to contractors from 34 % to 11,1 % and the time-to-pay for interim payments to project beneficiaries from 94 to 65 days in 2017; acknowledges in this respect that the average time-to-pay for final payments of costs claimed by beneficiaries was 52 days;
2019/01/30
Committee: CONT